Triastek collaborates with Eli Lilly and Company on 3D printing tech
The project will conduct an in-depth study of excipient properties and process parameters to maintain drug stability throughout the formulation development
Triastek | 14/07/2022 | By Sudeep Soparkar | 664
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy